...
首页> 外文期刊>FEBS Letters >Genes encoding human caveolin‐1 and ‐2 are co‐localized to the D7S522 locus (7q31.1), a known fragile site (FRA7G) that is frequently deleted in human cancers
【24h】

Genes encoding human caveolin‐1 and ‐2 are co‐localized to the D7S522 locus (7q31.1), a known fragile site (FRA7G) that is frequently deleted in human cancers

机译:编码人类小窝蛋白-1和-2的基因共定位于D7S522基因座(7q31.1),这是一个已知的脆弱位点(FRA7G),在人类癌症中经常被删除

获取原文
           

摘要

>The (CA)n microsatellite repeat marker D7S522 is located on human chromosome 7q31.1 and is frequently deleted in a variety of human cancers, including squamous cell carcinomas of the head and neck, prostate cancers, renal cell carcinomas, ovarian adenocarcinomas, colon carcinomas, and breast cancers. In addition, D7S522 spans FRA7G, a known common fragile site on human chromosome 7. Based on these studies, it has been proposed that an as yet unidentified tumor suppressor gene (or genes) is contained within or located in close proximity to this locus. However, the identity of the candidate tumor suppressor gene at the D7S522 locus remains unknown. Here, we show that the human genes encoding caveolins 1 and 2 are contained within the same human genomic BAC clones and co-localize to the q31.1-q31.2 region of human chromosome 7, as seen by FISH analysis. In addition, we determined the intron-exon boundaries of the human caveolin-1 and -2 genes. The human caveolin-1 gene contains three exons, while the human caveolin-2 gene contains two exons. Interestingly, the boundary of the last exon of the human caveolin-1 and caveolin-2 genes are analogous, suggesting that they arose through gene duplication at this locus. (CA)n microsatellite repeat marker analysis of these caveolin genomic clones indicates they contain the marker D7S522 (located at 7q31.1), but not other microsatellite repeat markers tested. The close proximity of caveolins 1 and 2 to the D7S522 locus was independently confirmed by using a panel of MIT/Whitehead human STS markers that are known to map in the neighborhood of the D7S522 locus. As it has been previously shown that caveolin 1 possesses transformation suppressor activity (Koleske, A.J., Baltimore, D. and M.P. Lisanti (1995) Proc. Natl. Acad. Sci. USA 92, 1381–1385; Engelman, J.A. et al. (1997) J. Biol. Chem. 272, 16374–16381), we propose that the caveolin-1 gene may represent the candidate tumor suppressor gene at the D7S522 locus on human chromosome 7q31.1.
机译:>(CA) n 微卫星重复标记D7S522位于人类染色体7q31.1上,在多种人类癌症中经常删除,包括头颈部鳞状细胞癌,前列腺癌,肾细胞癌,卵巢腺癌,结肠癌和乳腺癌。另外,D7S522跨越FRA7G,FRA7G是人类染色体7上的一个已知的常见易碎位点。基于这些研究,已经提出了一个尚未鉴定的肿瘤抑制基因(或多个基因)包含在该基因座内或紧邻该基因座。但是,候选肿瘤抑制基因在D7S522位点的身份仍然未知。在这里,我们显示了编码小窝蛋白1和2的人类基因包含在相同的人类基因组BAC克隆中,并且共定位于人类7号染色体的q31.1-q31.2区域,如FISH分析所示。此外,我们确定了人类caveolin-1和-2基因的内含子-外显子边界。人类caveolin-1基因包含三个外显子,而人类caveolin-2基因包含两个外显子。有趣的是,人类caveolin-1和caveolin-2基因的最后一个外显子的边界是相似的,表明它们是通过在该基因座处的基因复制而产生的。这些小窝蛋白基因组克隆的(CA) n 微卫星重复标记分析表明,它们包含标记D7S522(位于7q31.1),但未测试其他微卫星重复标记。通过使用一组已知在D7S522基因座附近作图的MIT / Whitehead人类STS标记,独立地证实了小窝蛋白1和2与D7S522基因座的紧密接近。如先前所显示的,小窝蛋白1具有转化抑制活性(Koleske,AJ,Baltimore,D. and MP Lisanti(1995)Proc.Natl.Acad.Sci.USA 92,1381–1385; Engelman,JA等( 1997)J. Biol。Chem。272,16374–16381),我们建议小窝蛋白1基因可能代表人类染色体7q31.1上D7S522位点的候选抑癌基因。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号